Evidence map›Paper›PMID 27117511›Full record

ArticleThe Journal of infectious diseases2016

In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation.

Neta Milman, Jia Zhu, Christine Johnston, Anqi Cheng, Amalia Magaret, David M Koelle, Meei-Li Huang, Lei Jin, Alexis Klock, Erik D Layton and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Neta MilmanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Jia ZhuVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Laboratory Medicine.
Christine JohnstonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Medicine.
Anqi ChengDepartment of Biostatistics.
Amalia MagaretVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Laboratory Medicine Department of Medicine Department of Biostatistics.
David M KoelleVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Laboratory Medicine Department of Medicine Department of Global Health, University of Washington, Seattle.
Meei-Li HuangDepartment of Laboratory Medicine.
Lei JinDepartment of Laboratory Medicine.
Alexis KlockDepartment of Laboratory Medicine.
Erik D LaytonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Lawrence CoreyVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Laboratory Medicine Department of Medicine.
Fred Hutch Cancer Center · USCancer Research Center · US

Funding

THE PERINATAL COMPLICATIONS OF ASYMPTOMATIC GENITAL HERPES SIMPLEX VIRUSP01AI030731 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, JIA · 1991 to 2017
$34.3M
Cytotoxic T-Cell Responses to HSV: HIV-Infected PersonsR37AI042528 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE · 2002 to 2011
$3.5M
CYTOTOXIC T CELL RESPONSES TO HSV IN HIV INFECTIONR01AI042528 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE, ZHU, JIA · 1998 to 2016
$2.7M
Genomic systems approach to measure HSV-1-specific T-cell dominance in humansR01AI094019 · NIAID · UNIVERSITY OF WASHINGTON · PI KOELLE, DAVID M · 2012 to 2016
$1.9M
Mechanisms of Protective Local Immunity in Human Female Reproductive TractR01AI111780 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, JIA · 2014 to 2018
$1.7M
Mechanisms of CD8+ T cell Immune surveillance in human genital skin and mucosa afR56AI093746 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, JIA · 2012 to 2012
$318k
NIAID NIH HHS P01 AI030731NIAID NIH HHS R01 AI042528NIAID NIH HHS R01 AI094019NIAID NIH HHS R01 AI111780NIAID NIH HHS R37 AI042528NIAID NIH HHS R56 AI093746
6 · The paper itself

Abstract

backgroundHerpes simplex virus type 2 (HSV-2) reactivation is accompanied by a sustained influx of CD4(+) and CD8(+) T cells that persist in genital tissue for extended periods. While CD4(+) T cells have long been recognized as being present in herpetic ulcerations, their role in subclinical reactivation and persistence is less well known, especially the role of CD4(+) regulatory T cells (Tregs).

methodsWe characterized the Treg (CD4(+)Foxp3(+)) population during human HSV-2 reactivation in situ in sequential genital skin biopsy specimens obtained from HSV-2-seropositive subjects at the time of lesion onset up to 8 weeks after healing.

resultsHigh numbers of Tregs infiltrated to the site of viral reactivation and persisted in proximity to conventional CD4(+) T cells (Tconvs) and CD8(+) T cells. Treg density peaked during the lesion stage of the reactivation. The number of Tregs from all time points (lesion, healed, 2 weeks after healing, 4 weeks after healing, and 8 weeks after healing) was significantly higher than in control biopsy specimens from unaffected skin. There was a direct correlation between HSV-2 titer and Treg density.

conclusionsThe association of a high Treg to Tconv ratio with high viral shedding suggests that the balance between regulatory and effector T cells influences human HSV-2 disease.

Indexed as

FemaleGenitaliaHerpes GenitalisHerpesvirus 2, HumanHumansMaleT-Lymphocytes, RegulatoryVirus ActivationVirus SheddingWashingtonFoxp3herpesHSV-2reactivationregulatory T cellsT cellsviral shedding

Identifiers

PMID27117511
PMCPMC4907414
OpenAlexW2417990144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.